Elizabeth H. Federici

Elizabeth H. Federici, MD is an Assistant Professor in the Department of Medicine, Division of Blood and Vascular Disorders at Penn State College of Medicine. She is affiliated with the Penn State Cancer Institute and focuses on clinical research in hematology, particularly outcomes for patients with hemophilia and thrombosis. Her work emphasizes optimizing treatments for invasive procedures in hemophilia patients and clarifying hereditary/acquired factors influencing thrombosis development.

Teaching roles include residency/fellowship education, recruitment, and course director for the Hematology clinical board. Clinical interests span bleeding disorders, platelet disorders, aplastic anemia, thrombosis/thrombophilias, and myeloproliferative diseases. Board-certified in Internal Medicine since 2016, her research aligns with UN Sustainable Development Goals related to health equity and non-communicable disease control.

Key research areas include reduced-dose anticoagulation strategies, post-transfusion responses in cirrhosis, and genetic thrombosis risks. Recent publications (2019-2025) address clinical management of thromboembolism, exercise interventions during chemotherapy, and genetic mutation impacts.

Recipient of awards including the 2016 Best Inpatient Resident award and 2024 Dean's Award for Excellence in Teaching. Collaborates internationally on thrombosis-related studies through networks like VENUS.